Clinical Evidence-Guided Anti-rheumatoid Arthritis Study of Shuji Tablet in Adjuvant-Induced Arthritis Rats and Mechanism Exploration via Network Pharmacological Approach

Clinical Evidence-Guided Anti-rheumatoid Arthritis Study of Shuji Tablet in Adjuvant-Induced Arthritis Rats and Mechanism Exploration via Network Pharmacological Approach

Background: Rheumatoid arthritis (RA) is a kind of chronic autoimmune disease with several tissues damaged. Shuji tablet (SJT) is a prescription approved for treating lumbago and leg pain in the clinic. However, the efficacy of SJT against RA is still unknown. This study aims to evaluate the therape...

Full description

Bibliographic Details
Main Authors: Weibo Dai, Jing Yang, Haili Cao, Zhuqiang Wang, Guangru Li, Xiwen Zhong, Weiwen Peng, Chang Chen, Xin Liu, Congyan Zeng, Xianjing Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
Shuji tablet
rheumatoid arthritis
network pharmacology
traditional Chinese medicine
adjuvant-induced arthritis
mechanism
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.694507/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.694507/full

Similar Items